AAM outlines policy solutions for sustained patient access to generic and biosimilar medicines
WASHINGTON – Today the Association for Accessible Medicines (AAM) and its Biosimilars Council shared their policy priorities for the Biden administration and 117th Congress, highlighting solutions to maintain the sustainability of generic and biosimilar competition. In parallel, AAM launched a new advocacy campaign, “Secure Our Meds,” which includes a series of reports emphasizing the importance and
